Hosted on MSN54m
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars
Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...
The Daily Chase: Plenty of earnings to digest
There are a slew of quarterly results to digest from TSX-listed firms this morning, perhaps none more notable than oil ...